Rare disease biotech BioMarin Pharmaceuticals Inc. announced Friday it was shedding around 4% of its global workforce, or around 120 jobs, in an effort to improve its operational efficiency.
https://www.pharmalive.com/wp-content/uploads/2022/10/BiospaceBiomarin10-7-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-10-07 12:04:102022-10-07 12:04:10BioMarin, Cyclerion slash workforce in the name of strategic focus
